Found: 67
Select item for more details and to access through your institution.
Determinants of physiologic 18F-FDG uptake in brown adipose tissue in sequential PET/CT examinations.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 7, p. 1229, doi. 10.1007/s00432-013-1436-y
- By:
- Publication type:
- Article
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 291, doi. 10.3390/jpm10040291
- By:
- Publication type:
- Article
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01797-3
- By:
- Publication type:
- Article
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14534, doi. 10.3390/ijms232314534
- By:
- Publication type:
- Article
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3528, doi. 10.3390/ijms21103528
- By:
- Publication type:
- Article
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 103, doi. 10.1007/s10549-021-06371-9
- By:
- Publication type:
- Article
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1525, doi. 10.3390/jcm10071525
- By:
- Publication type:
- Article
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 254, doi. 10.3390/jcm8020254
- By:
- Publication type:
- Article
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 542, doi. 10.3390/jcm7120542
- By:
- Publication type:
- Article
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
- By:
- Publication type:
- Article
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 191, doi. 10.3390/vaccines8020191
- By:
- Publication type:
- Article
Prognostic value of [18F]-FDG PET/CT in patients with metastatic breast cancer treated with cyclin-dependent inhibitors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193174
- By:
- Publication type:
- Article
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1177681
- By:
- Publication type:
- Article
Breast and cervical cancer in transgender men: literature review and a case report.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241259466
- By:
- Publication type:
- Article
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 11, p. 7900, doi. 10.1002/jcp.29445
- By:
- Publication type:
- Article
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 7708, doi. 10.1002/jcp.27832
- By:
- Publication type:
- Article
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
- Published in:
- Scientific Reports, 2016, p. 35121, doi. 10.1038/srep35121
- By:
- Publication type:
- Article
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059873
- By:
- Publication type:
- Article
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059873
- By:
- Publication type:
- Article
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919853192
- By:
- Publication type:
- Article
Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069269
- By:
- Publication type:
- Article
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2628, doi. 10.3390/cancers16152628
- By:
- Publication type:
- Article
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4835, doi. 10.3390/cancers14194835
- By:
- Publication type:
- Article
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4061, doi. 10.3390/cancers13164061
- By:
- Publication type:
- Article
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 332, doi. 10.3390/cancers13020332
- By:
- Publication type:
- Article
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2497, doi. 10.3390/cancers12092497
- By:
- Publication type:
- Article
Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 849, doi. 10.3390/cancers12040849
- By:
- Publication type:
- Article
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 10, p. 2235, doi. 10.7150/ijms.54025
- By:
- Publication type:
- Article
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 10, p. 2245, doi. 10.7150/ijms.54996
- By:
- Publication type:
- Article
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 1, p. 73, doi. 10.1007/s10549-014-3138-9
- By:
- Publication type:
- Article
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 3, p. 599, doi. 10.1007/s10549-014-3133-1
- By:
- Publication type:
- Article
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 2, p. 227, doi. 10.1007/s10549-014-3087-3
- By:
- Publication type:
- Article
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 141, n. 1, p. 119, doi. 10.1007/s10549-013-2675-y
- By:
- Publication type:
- Article
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.797157
- By:
- Publication type:
- Article
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919853192
- By:
- Publication type:
- Article
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/s13046-015-0143-8
- By:
- Publication type:
- Article
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-67
- By:
- Publication type:
- Article
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-49
- By:
- Publication type:
- Article
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 1, doi. 10.1186/1756-9966-31-4
- By:
- Publication type:
- Article
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2011, v. 30, n. 1, p. 39, doi. 10.1186/1756-9966-30-39
- By:
- Publication type:
- Article
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0338-7
- By:
- Publication type:
- Article
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92774-z
- By:
- Publication type:
- Article
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1917, doi. 10.1002/ijc.32583
- By:
- Publication type:
- Article
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 11, p. 2587, doi. 10.1002/ijc.30668
- By:
- Publication type:
- Article
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149872
- By:
- Publication type:
- Article